Table 4 Comparison of serum inflammatory factors between the two groups before and after treatment
From: The clinical efficacy and safety of dapagliflozin in patients with diabetic nephropathy
Groups | N | IL-6 (pg/ml) | TNF-α (pg/ml) | ||
|---|---|---|---|---|---|
Before treatment | After treatment | Before treatment | After treatment | ||
Control group | 60 | 75.77 ± 18.24 | 49.17 ± 13.68* | 73.86 ± 26.44 | 41.57 ± 9.36* |
Experimental group | 60 | 73.18 ± 17.02 | 37.43 ± 12.16*# | 70.84 ± 24.25 | 32.01 ± 8.21*# |